NCT00412867View on ClinicalTrials.gov

Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Stroke
Interventions
DRUG

Alteplase

0.6 mg/kg of Alteplase is intravenously administered

Trial Locations (1)

Unknown

Investigational site 01, Hokkaido

Sponsors
All Listed Sponsors
collaborator

Kyowa Kirin Co., Ltd.

INDUSTRY

lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY